[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE11499A1 - Tratamiento del hiv y cancer - Google Patents

Tratamiento del hiv y cancer

Info

Publication number
PE11499A1
PE11499A1 PE1997000894A PE00089497A PE11499A1 PE 11499 A1 PE11499 A1 PE 11499A1 PE 1997000894 A PE1997000894 A PE 1997000894A PE 00089497 A PE00089497 A PE 00089497A PE 11499 A1 PE11499 A1 PE 11499A1
Authority
PE
Peru
Prior art keywords
cancer
agent
agents
dipinomycin
herbicide
Prior art date
Application number
PE1997000894A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE11499A1 publication Critical patent/PE11499A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE AL USO DE ANTIFUNGICOS Y HERBICIDAS JUNTO CON REFORZADORES Y/O AGENTES ANTIVIRALES Y/O AGENTES QUIMIOTERAPEUTICOS, EN EL TRATAMIENTO DE LAS INFECCIONES VIRALES, COMO HIV, Y CANCER; EN DONDE: EL ANTIFUNGICO ES UN DERIVADO DE BENCIMIDAZOL, TIABENCIMIDAZOL, 1H-1,2,4-TRIAZOL, 1,3-BIS-TRIAZOLIL-2-PROPANOL, GRISEOFULVINA, DE PREFERENCIA DICHO FUNGICIDA ES TIABENDAZOL; EL HERBICIDA ES UN DERIVADO DE N-CLOROFENILCARBAMATO Y N-CLOROFENILTIOCARBAMATO, N-FOSFONOGLICINA, DE PREFERENCIA DICHO HERBICIDA ES CLOROPROFAN; EL REFORZADOR ES EL ACIDO 1-H-BENCIMIDAZOL-2-PROPANOICO (PROCODAZOL), ENTRE OTROS; EL AGENTE ANTIVIRAL ES AZT o 3TC; EL AGENTE QUIMIOTERAPEUTICO ES UN AGENTE INTERACTIVO DEL DNA, AGENTE INTERACTIVO DE TUBULINA o ANTIMETABOLITO COMO: ASPARAGINASA, HIDROXIUREA, CISPLATIN, CICLOFOSFAMIDA, ALTRETAMINA, BLEOMICIN, DACTINOMICIN, DOXORUBICIN, ETOPOSIDO, TENIPOSIDO, PLICAMICIN o TAXOL. LOS AGENTES HERBICIDAS SON EFECTIVOS CUANDO EL CANCER O VIRUS ES UNA CELULA ANIMAL GENETICAMENTE ALTERADA Y LOS AGENTE FUNGICIDAS SON EFECTIVOS CUANDO EL CANCER O VIRUS ES UNA CELULA ANIMAL QUE CONTIENE MATERIALES GENETICOS DERIVADOS DE HONGOS O MOHOS
PE1997000894A 1997-05-16 1997-10-09 Tratamiento del hiv y cancer PE11499A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4672697P 1997-05-16 1997-05-16

Publications (1)

Publication Number Publication Date
PE11499A1 true PE11499A1 (es) 1999-03-01

Family

ID=21945046

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000894A PE11499A1 (es) 1997-05-16 1997-10-09 Tratamiento del hiv y cancer

Country Status (19)

Country Link
EP (1) EP0954309A1 (es)
JP (1) JP2000510156A (es)
KR (1) KR20000049064A (es)
CN (1) CN1254281A (es)
AR (1) AR009968A1 (es)
AU (1) AU7402998A (es)
BR (1) BR9712981A (es)
CA (1) CA2268848A1 (es)
CO (1) CO5070657A1 (es)
CZ (1) CZ124999A3 (es)
HU (1) HUP9904092A3 (es)
IL (1) IL129351A0 (es)
NO (1) NO991701L (es)
PE (1) PE11499A1 (es)
PL (1) PL335160A1 (es)
SK (1) SK46999A3 (es)
TR (1) TR199901530T2 (es)
WO (1) WO1998051303A1 (es)
ZA (1) ZA979095B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
WO2000050021A2 (en) * 1999-02-26 2000-08-31 Napro Biotherapeutics, Inc. Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started
CA2366697A1 (en) * 1999-02-26 2000-08-31 Larry Helson Treatment regimen for hormone-sensitive cancers
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
AU2001286744A1 (en) * 2000-08-25 2002-03-04 Beth Israel Deaconess Medical Center Compounds and methods for inhibiting neuronal cell death
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
AU9279601A (en) * 2000-09-26 2002-04-08 Procter & Gamble Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
WO2002041891A2 (en) * 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles
JP2004115397A (ja) * 2002-09-25 2004-04-15 Fuji Photo Film Co Ltd 血管疾患治療薬を含むリポソーム
AU2005313839B2 (en) * 2004-12-06 2010-03-11 Pitney Pharmaceuticals Pty Limited Treatment for cancer
EP1830847B1 (en) 2004-12-06 2014-11-19 Pitney Pharmaceuticals Pty Limited Treatment for cancer
US7727967B2 (en) * 2006-02-24 2010-06-01 Boise State University Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines
WO2009043093A1 (en) * 2007-10-04 2009-04-09 Newsouth Innovations Pty Limited Hif inhibition
CN101643729B (zh) * 2008-08-07 2011-12-28 复旦大学 核酸分子nrn1sr22及其在制备抗癌药物中的应用
EP3119768B1 (en) 2014-03-16 2019-07-31 Hadasit Medical Research Services And Development Ltd. 3,4-bromo or -sulfonate substituted 1h-pyrrole-2,5-dione derivatives as type iii deiodinase (dio3) inhibitors for treating depressions and cancer
CN105418711A (zh) * 2015-11-06 2016-03-23 山东大学 一种α-L-鼠李糖苷酶在制备羟基脲糖苷衍生物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090186C (zh) * 1993-03-31 2002-09-04 麦克公司 治疗aids药物组合物中的hiv蛋白酶抑制剂
US5656615A (en) * 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
WO1996032104A1 (en) * 1995-04-12 1996-10-17 The Procter & Gamble Company A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
HUP9903420A3 (en) * 1995-08-04 2001-12-28 Procter & Gamble Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections

Also Published As

Publication number Publication date
CO5070657A1 (es) 2001-08-28
NO991701D0 (no) 1999-04-09
SK46999A3 (en) 2000-05-16
BR9712981A (pt) 2000-04-18
HUP9904092A2 (hu) 2000-04-28
WO1998051303A1 (en) 1998-11-19
CA2268848A1 (en) 1998-11-19
EP0954309A1 (en) 1999-11-10
ZA979095B (en) 1998-05-11
JP2000510156A (ja) 2000-08-08
NO991701L (no) 2000-01-17
HUP9904092A3 (en) 2000-07-28
TR199901530T2 (xx) 1999-10-21
PL335160A1 (en) 2000-04-10
CZ124999A3 (cs) 1999-09-15
IL129351A0 (en) 2000-02-17
AU7402998A (en) 1998-12-08
CN1254281A (zh) 2000-05-24
KR20000049064A (ko) 2000-07-25
AR009968A1 (es) 2000-05-17

Similar Documents

Publication Publication Date Title
PE11499A1 (es) Tratamiento del hiv y cancer
ES2178720T3 (es) Mezclas herbicidas sinergicas.
DK0510458T3 (da) Mikrobicide kombinationer af aktive stoffer
BR9911125B1 (pt) composição inseticida e fungicida sinérgica para o combate de pragas vegetais, seus processos de preparação e uso, bem como processo para o combate de fungos e insetos.
CU22867A3 (es) Composicion herbicidal
CL2013000860A1 (es) Combinaciones sinergicas de productos activos fungicidas que contiene carboxamida y al menos un compuesto seleccionado de propiconazol, epoxiconazol, protioconazol, tebuconazol y bitertanol; uso para la lucha contra fitopatogenos indeseados. (divisional de sol. 2729-2004)
ITMI931025A1 (it) Erbicidi per la lotta contro piante infestanti in coltivazioni di riso
ATE24909T1 (de) Antifungale triazole.
NO923330L (no) Vannbaserte, opploesningsmiddel- og emulgatorfrie bioside virkestoffkombinasjoner
ES2191275T3 (es) Agente de conservacion algicida y fungicida con actividad anti-alternaria.
IL98153A0 (en) Agent for preserving wood or wood-based materials containing at least one fungicide and/or at least one insecticide
MY121591A (en) Herbicidal compositions containing triazolinones
ITMI932282A1 (it) Erbicidi per la lotta contro piante infestanti in coltivazioni di riso
ATE260559T1 (de) Sordarinderivate
Gibbons Asian gypsy moth jumps ship to United States
RU98100272A (ru) Фунгицидные комбинации активных веществ
DK175683D0 (da) Fungicidt middel
DE69813833D1 (de) 4-cyano-4-deformylsordarizin-derivate
GR880100229A (el) Βιοπαρασιτοκτονα για χρησιμοποιηση επι φυτων που περιεχουν ταννινη
Winder et al. Terminology in microbial control of weeds
Cunningham et al. Orgyia pseudotsugata(McDunnough), Douglas-fir tussock moth(Lepidoptera: Lymantriidae).
Sherris Skin and wound infections.
Jayaraj et al. Microbial control of insects using fungal pathogens.
Johnsen et al. The culmination of the Chrysochromulina polylepis(Manton and Parke) bloom along the western coast of Norway.
Ruano Rossil Unintended effects of potato late blight fungicides over the proliferation of green peach aphid, Myzus persicae (Sulzer).

Legal Events

Date Code Title Description
FC Refusal